Assembly Biosciences Stock Technical Analysis
| ASMB Stock | USD 29.68 0.16 0.54% |
As of the 3rd of March, Assembly Biosciences shows the Standard Deviation of 4.07, mean deviation of 3.0, and Risk Adjusted Performance of (0.05). Assembly Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Assembly Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Assembly, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AssemblyAssembly Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Assembly Biosciences Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 47.75 | Strong Buy | 2 | Odds |
Most Assembly analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Assembly stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Assembly Biosciences, talking to its executives and customers, or listening to Assembly conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.60) | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Assembly Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Assembly Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Assembly Biosciences.
| 12/03/2025 |
| 03/03/2026 |
If you would invest 0.00 in Assembly Biosciences on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Assembly Biosciences or generate 0.0% return on investment in Assembly Biosciences over 90 days. Assembly Biosciences is related to or competes with Zura Bio, Foghorn Therapeutics, Immuneering Corp, Sagimet Biosciences, Enanta Pharmaceuticals, Aardvark Therapeutics, and Nautilus Biotechnology. Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for th... More
Assembly Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Assembly Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Assembly Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 19.1 | |||
| Value At Risk | (8.75) | |||
| Potential Upside | 5.85 |
Assembly Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assembly Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Assembly Biosciences' standard deviation. In reality, there are many statistical measures that can use Assembly Biosciences historical prices to predict the future Assembly Biosciences' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.33) |
Assembly Biosciences March 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.32) | |||
| Mean Deviation | 3.0 | |||
| Coefficient Of Variation | (1,412) | |||
| Standard Deviation | 4.07 | |||
| Variance | 16.58 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.33) | |||
| Maximum Drawdown | 19.1 | |||
| Value At Risk | (8.75) | |||
| Potential Upside | 5.85 | |||
| Skewness | (0.21) | |||
| Kurtosis | 0.9175 |
Assembly Biosciences Backtested Returns
Assembly Biosciences secures Sharpe Ratio (or Efficiency) of -0.0481, which signifies that the company had a -0.0481 % return per unit of risk over the last 3 months. Assembly Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Assembly Biosciences' Risk Adjusted Performance of (0.05), mean deviation of 3.0, and Standard Deviation of 4.07 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.91, which signifies possible diversification benefits within a given portfolio. Assembly Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Assembly Biosciences is expected to follow. At this point, Assembly Biosciences has a negative expected return of -0.19%. Please make sure to confirm Assembly Biosciences' kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Assembly Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.64 |
Very good reverse predictability
Assembly Biosciences has very good reverse predictability. Overlapping area represents the amount of predictability between Assembly Biosciences time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Assembly Biosciences price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current Assembly Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.64 | |
| Spearman Rank Test | -0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 1.9 |
Assembly Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Assembly Biosciences Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Assembly Biosciences across different markets.
About Assembly Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Assembly Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Assembly Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Assembly Biosciences price pattern first instead of the macroeconomic environment surrounding Assembly Biosciences. By analyzing Assembly Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Assembly Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Assembly Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.86 | 0.59 | 0.56 | Revenue Per Share | 1.56 | 5.46 | 6.93 |
Assembly Biosciences March 3, 2026 Technical Indicators
Most technical analysis of Assembly help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Assembly from various momentum indicators to cycle indicators. When you analyze Assembly charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.32) | |||
| Mean Deviation | 3.0 | |||
| Coefficient Of Variation | (1,412) | |||
| Standard Deviation | 4.07 | |||
| Variance | 16.58 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.33) | |||
| Maximum Drawdown | 19.1 | |||
| Value At Risk | (8.75) | |||
| Potential Upside | 5.85 | |||
| Skewness | (0.21) | |||
| Kurtosis | 0.9175 |
Assembly Biosciences March 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Assembly stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2,405 | ||
| Daily Balance Of Power | (0.14) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 29.66 | ||
| Day Typical Price | 29.67 | ||
| Price Action Indicator | (0.06) |
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |